Ménière’s disease remains a complex and often debilitating condition, affecting balance and hearing through symptoms such as vertigo, tinnitus, and fluctuating hearing loss. The Ménière’s Disease Symposium, held February 21 at the ARO (Association for Research in Otolaryngology) MidWinter Meeting, brought together clinicians and researchers to discuss the latest advancements in diagnosis, treatments, and future investigative directions.
The event opened with a patient’s perspective on living with Ménière’s disease and how it can drastically affect quality of life. Many of the attendees, who were primarily researchers and clinicians, expressed appreciation that the speaker shared her experience, noting that the patient perspective is too rarely included in research symposia and conferences.
From the individual experience to the long-term picture, the symposium also included a talk that provided an overview of the history of the condition. In 1861 Prosper Ménière first described the disease, notably linking vertigo to the inner ear instead of the brain. The various attempted treatments since then have ranged from bloodletting to surgical interventions in the inner ear.
On the YouTube player, click “cc” for captions. Click here for full transcript.
Clinician-scientists discussed the challenges in diagnosing and treating Ménière’s disease. Current clinical care lacks strong evidence-based treatments, with commonly used therapies showing limited scientific support despite observed patient improvements. The range of symptoms that fluctuate may point to the need to define subtypes of the disease and/or redefine it as a syndrome.
Because research indicates significant overlap with vestibular migraine, the potential for drugs targeting molecular pathways for migraine-related symptoms was highlighted. However, challenges for clinical trials in this area were noted along with the need for improved future trial designs.
Also presented were advancements in MRI imaging that have enabled the visualization of endolymphatic hydrops in Ménière's disease patients. Modern radiological assessments now provide detailed evaluations of endolymphatic structures, aiding in disease subtyping and treatment planning.
Another advance highlighted is how genetic studies have identified several genes linked to familial Ménière’s disease, suggesting a genetic component. Also explored was the role of inflammation and immune system responses in disease progression, which has led to the identification of promising potential treatment targets in early studies.
Ménière's disease has been viewed as primarily caused by fluid pressure, but it was suggested that endolymphatic hydrops may instead be a compensatory response to inner ear injury. This represents a new disease model similar to chronic organ disorders involving an initial injury, compensatory mechanisms, fluctuating function, and eventual progression to irreversible damage.
Beyond physical symptoms, Ménière’s disease can take a significant psychological toll. Cognitive behavioral therapy and mindfulness techniques were recommended to help patients manage stress and anxiety. These strategies, when integrated into a comprehensive treatment plan, may improve overall patient quality of life.
Despite scientific advancements, challenges in Ménière’s disease research persist. Some of the needs expressed by the presenters were standardized diagnostic criteria and biomarkers to enhance research consistency; multi-center clinical trials to spur collaboration and improve study reliability and patient diversity; and the development of animal models that accurately reflect human disease mechanisms.
While significant challenges remain, ongoing efforts in genetic research, immunology, and clinical trials offer hope for better management and potential cures in the future.
The symposium’s organizational sponsors were American Hearing Research Foundation and Hearing Health Foundation, along with sponsors Spiral Therapeutics and Scott Dorsey and organizational partners Cures Within Reach and the Vestibular Disorders Association.
The video, supplied by ARO, contains captioned slides and audio. For detailed presenter information, see hhf.org/menieres-disease-symposium.
The Latest Blog Posts
While significant challenges remain, ongoing efforts in genetic research, immunology, and clinical trials offer hope for better management and potential cures for Ménière’s disease in the future.